Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Justices' Hikma Reasoning May Extend Well Beyond Pharma
In a unanimous victory for the generic drug industry, on June 4 the U.S. Supreme Court reversed the U.S. Court of Appeals for the Federal Circuit's decision in Hikma Pharmaceuticals USA Inc.... To view the full article, register now. Already a…
Odyssean LLC Invests $3.06 Million in BridgeBio Pharma, Inc. $BBIO
Odyssean LLC acquired a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional…
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Receives Average Recommendation of 'Moderate Buy' from Brokerages
Shares of Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) have received a consensus recommendation of 'Moderate Buy' from the six analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has…
BioMarin (BMRN) Secured 20% U.S. Royalties on Yuviwel. Is Monetizing a Rival Better than Blocking It?
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has converted a global patent dispute with Ascendis Pharma A/S (NASDAQ:ASND) into a royalty-bearing license for Yuviwel, a once-weekly treatment approved to increase linear growth in children aged 2 years…
Orion Corporation: Acquisition of own shares during week 36, 2026
STOCK EXCHANGE RELEASE – CHANGES IN COMPANY'S OWN SHARES Orion Corporation: Acquisition of own shares during week 36, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The…
Trump's Drug Deals Are Working. Here's What Could Make Them Work Even Better.
President Donald Trump promised lower healthcare costs, and he's bringing lower healthcare costs. This week, Trump announced more voluntary deals with drug manufacturers under which they agreed to cut their U.S. prices to the rates they charge in…
Explore Timekettle W4 Plus: The Ultimate AI Interpreter Earbuds
Timekettle has officially taken the wraps off its W4 Plus AI Interpreter Earbuds at IFA 2026 in Berlin. Serving as a direct follow-up to the W4 platform introduced in 2025, the new semi-in-ear wearable is designed for global business travelers…
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Given Average Rating of 'Moderate Buy' by Analysts
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) has been assigned a consensus rating of 'Moderate Buy' from the ten ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock…
Growth Stocks To Follow Now - September 4th
Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Ascendis Pharma A/S, Andersen Group, Tyra Biosciences, Teledyne Technologies, Hamilton Lane, and Jersey Mike's are the seven Growth stocks to watch today, according to…
Nykredit A S Purchases New Position in Teva Pharmaceutical Industries Ltd. $TEVA
Nykredit A S purchased a new stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund purchased 443,442 shares of the company's…
Abhayrab rabies vaccine batch flagged as substandard in India
India's drug regulator has flagged a batch of widely used rabies vaccine Abhayrab as substandard and potentially spurious after it failed a potency test, a government document seen by Reuters shows. The finding marks the second time…
NEOS Investment Management LLC Has $22.41 Million Stock Holdings in Pfizer Inc. $PFE
NEOS Investment Management LLC increased its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 13.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor…
Pfizer (NYSE:PFE) Downgraded by Wall Street Zen to 'Hold'
Pfizer (NYSE:PFE - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a 'buy' rating to a 'hold' rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports. The Phase 3 Failure That…
Pfizer (NYSE:PFE) Shares Down 1.4% - What's Next?
Pfizer Inc. (NYSE:PFE - Get Free Report) shares traded down 1.4% during mid-day trading on Friday. The company traded as low as $28.38 and last traded at $28.42. Approximately 23,419,310 shares changed hands during mid-day trading, a decline of 44%…
Two Sigma Securities LLC Purchases New Holdings in Eli Lilly and Company $LLY
Two Sigma Securities LLC purchased a new position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Receive a Daily briefing on Pharma Industry News
Get Started